Construction and Validation of a Novel Nomogram for Predicting the Recurrence of Diffuse Large B Cell Lymphoma Treated with R-CHOP.

Yuxi Gong,Haitao Yan,Yefan Yang,Boya Zhai, Zhendong Huang,Zhihong Zhang

Pharmacogenomics and personalized medicine（2023）

引用 2|浏览17

暂无评分

摘要

The novel nomogram incorporating the three independent risk factors (BCL2 expression, CD10 expression and LDH level) provided a valuable tool for predicting DLBCL recurrence.

查看译文

关键词

DLBCL,diffuse large B cell lymphoma,nomogram,recurrence,risk factors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要